Antibody Fragment Conjugate Mixture
Mixed biotech preparation of antibody fragments and conjugates for targeted drug delivery in immunology. HTS 3002.14.00 for mixed, non-retail immunological products per chapter definition of MAB fragments and conjugates.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | +100.0% | 100% |
| 🇲🇽Mexico | Free | +100.0% | 100% |
| 🇨🇦Canada | Free | +100.0% | 100% |
| 🇩🇪Germany | Free | +15.0% | 15% |
| 🇯🇵Japan | Free | +15.0% | 15% |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If single unmixed antibody conjugate
Unmixed products treated separately under chapter note.
If for diagnostic instrument use
Immunological products integral to medical instruments classify under 9018.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.
Import Tips & Compliance
• COA must specify multiple components (fragments + conjugates) as mixed
• Comply with CBP biotech import rules; temperature-controlled shipping mandatory
Related Products under HTS 3002.14.00
Colony Stimulating Factor and Interferon Mix
Bulk blend of CSF and IFN for enhancing immune response in chemotherapy patients. Fits 3002.14.00 as mixed immunological products (CSF, IFN) not put up for retail.
Mixed Interleukin and TNF Preparation
Combined IL and TNF modulators for rheumatoid arthritis therapy in bulk form. 3002.14.00 for mixed interleukins/TNF immunologicals.
Biotech Antibody and Chemokine Solution
Mixed MAB and chemokine solution for inflammation control. HTS 3002.14.00 applies.
Growth Factor and MAB Blend
Bulk GF-MAB mix for wound healing immunology.
Hematopoietin Antibody Cocktail
Mixed hematopoietin and antibody for blood disorders.
Mixed Monoclonal Antibody Cocktail for Cancer Therapy
A blended preparation of multiple monoclonal antibodies (MABs) such as trastuzumab and pertuzumab for targeted cancer immunotherapy. Classified under HTS 3002.14.00 as mixed immunological products not in measured doses or retail packaging, involving peptides and proteins regulating immunological processes.